New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ginkgo Bioworks Holdings, Inc.
DNA
Shape
US Flag

NYSE

Unprofitable

Unprofitable

490M

Biotechnology

Next Earning date - 13 Nov 2024

490M

Biotechnology

Next Earning date - 13 Nov 2024

8.81USD
Shape-0.07 ( -0.76%)
Market Open
favorite-chart

Relative Strenght

0
favorite-chart

Volume Buzz

-80%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

88%

Quote Panel

Shape
Updated October 21, 2024
1W 13.99 % 1M 13.41 % 3M -22.38 % 1Y -85.10 %

Key Metrics

Shape
  • Market Cap

    489.76M


  • Shares Outstanding

    55.58M


  • Share in Float

    45.69M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    8.8125


  • Average Volume

    1.43M


  • Beta

    1.102


  • Range

    5.26-75.2


  • Industry

    Biotechnology


  • Website

    https://www.ginkgobioworks.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.66x

P/S Ratio

0.54x

P/B Ratio

0.5

Debt/Equity

-487.0%

Net Margin

$-18.0

EPS

How DNA compares to sector?

P/E Ratio

Relative Strength

Shape

DNA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$209M

Shape273%

2025-Revenue

$7.17

Shape-69%

2025-EPS

$209M

Shape-57%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

BTIG

downgrade

Previous: Buy

2024-05-15

Now: Sell

William Blair

downgrade

Previous: Not converted

2024-05-10

Now: Underperform

CLSA

downgrade

Previous: Not converted

2022-08-16

Now: Sell

Bank of America Securities

downgrade

Previous: Not converted

2022-05-18

Now: Underperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.40
vs -0.07

Q4.22

arrow
arrow

N/A

-0.04
vs -0.01

Q1.23

arrow
arrow

N/A

-0.08
vs -0.05

Q2.23

arrow
arrow

N/A

-0.09
vs -0.41

Q3.23

arrow
arrow

N/A

-0.09
vs -0.40

Q4.23

arrow
arrow

N/A

-0.09
vs -0.04

Q1.24

arrow
arrow

N/A

-0.08
vs -0.08

Q2.24

arrow
arrow

N/A

-3.20
vs -0.09

Q3.24

arrow
arrow

N/A

-2.73
vs -0.09

Q4.24

arrow
arrow

N/A

-2.35
vs -0.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-14%

66.4M  vs 77.6M

Q4.22

arrow
arrow

-34%

98.3M  vs 148.5M

Q1.23

arrow
arrow

-52%

80.7M  vs 168.4M

Q2.23

arrow
arrow

-44%

80.6M  vs 144.6M

Q3.23

arrow
arrow

-17%

55.4M  vs 66.4M

Q4.23

arrow
arrow

-65%

34.8M  vs 98.3M

Q1.24

arrow
arrow

-53%

37.9M  vs 80.7M

Q2.24

arrow
arrow

-30%

56.2M  vs 80.6M

Q3.24

arrow
arrow

-19%

45M  vs 55.4M

Q4.24

arrow
arrow

+38%

47.9M  vs 34.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-47%

-0.47
vs -0.44

Q4.22

arrow
arrow

-10%

-0.10
vs -0.47

Q1.23

arrow
arrow

-13%

-0.13
vs -0.10

Q2.23

arrow
arrow

-12%

-0.12
vs -0.13

Q3.23

arrow
arrow

-24%

-0.24
vs -0.12

Q4.23

arrow
arrow

-19%

-0.19
vs -0.24

Q1.24

arrow
arrow

-17%

-0.17
vs -0.19

Q2.24

arrow
arrow

-26%

-0.26
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

292

292
vs 276

6%

Q4.22

arrow
arrow

341

341
vs 292

17%

Q1.23

arrow
arrow

321

321
vs 341

-6%

Q2.23

arrow
arrow

323

323
vs 321

1%

Q3.23

arrow
arrow

356

356
vs 323

10%

Q4.23

arrow
arrow

352

352
vs 356

-1%

Q1.24

arrow
arrow

345

345
vs 352

-2%

Q2.24

arrow
arrow

319

319
vs 345

-8%

Earnings Growth

Latest News